跳至主要内容
临床试验/CTRI/2022/01/039632
CTRI/2022/01/039632招募中未知

Efficacy of intravitreal dexamethasone injection in chronic, atypical, and recurrent central serous chorioretinopathy. A prospective pilot study. - NI

Hyderabad Eye Research Foundation0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with non-resolving and recurrent CSCR with focal, multifocal, or diffuse leaks on FA
  • 2. Eyes with focal leaks within 1000microns of the center of fovea in chronic CSCR
  • 3. Best corrected vision score of 73 to 34 at test distance of 4 meters on ETDRS chart at recruitment (Snellen equivalent 20/40 to 20/200)
  • 4. Decrease in vision primarily secondary to CSCR
  • 5. Willing to sign informed consent form

排除标准

  • 1. Laser or pharmacological treatment for CSCR in previous six months
  • 2. Eyes with choroidal neovascularization demonstrated on OCTA/FA/ICGA
  • 3. Fellow eye vision worse than 20/200
  • 4. Aphakia
  • 5. Patients with glaucoma.

研究者

相似试验